Anti-IL-2 receptor BT563 versus placebo: a randomized trial for induction therapy after liver transplantation

By Glanemann M.   Langrehr J.M.   Raakow R.   Guckelberger O.   Lohmann R.   Klupp J.   Lobeck H.   Schlag H.   Keck H.   Bechstein W.O.   Settmacher U.   Neuhaus P.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 2159-2160

Elsevier

Access to resources Recommend Favorite

Quadruple induction therapy including antithymocyte globulin or interleukin-2 receptor antibody or FK 506-based induction therapy after liver transplantation

By Lohmann R.   Langrehr J.M.   Klupp J.   Neumann U.   Guckelberger O.   Muller A.R.   Nussler N.C.   Jonas S.   Lang M.   Settmacher U.   Bechstein W.-O.   Neuhaus P.J.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 380-380

Elsevier

Access to resources Recommend Favorite

Immunological effects of the anti-IL-2 receptor monoclonal antibody BT 563 in liver allografted patients

By Nashan B.   Schwinzer R.   Schlitt H.   Wonigeit K.   Pichlmayr R.  

Transplant Immunology, Vol. 3, Iss. 3, 1995-09 ,pp. : 203-211

Elsevier

Access to resources Recommend Favorite

Comparison of Quadruple Induction Including ATG or IL-2R Antibody With FK506-Based Therapy After Liver Transplantation

By Langrehr J.M.   Schneller A.   Guckelberger O.   Lohmann R.   Neumann U.   Jonas S.   Klupp J.   Settmacher U.   Knoop M.   Bechstein W.O.   Neuhaus P.J.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1439-1440

Elsevier

Access to resources Recommend Favorite

T-lymphocyte kinetics in acute rejection after orthotopic liver transplantation

By Cuomo O.   Sbreglia C.   Militerno G.   Atripaldi L.   Darretta G.   Perrella A.   Perrella O.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3303-3303

Elsevier

Access to resources Recommend Favorite